Fig. 4From: CYP19A1 promotes gastric cancer as part of a lipid metabolism-related gene signature related to the response of immunotherapy and prognosisDifferences in immunity between two subtypes. Note: A and B The immune cells and immune functions of two subtypes were estimated. C and D The expression level of immune checkpoints and immune checkpoints’ scores were compared between patients in LM1 and LM2Back to article page